Effects of maple syrup urine disease metabolites on mouse L-fibroblasts in vitro: a fine structural and biochemical study.
D000818:Animals; D002210:Caprylates / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects; D002855:Chromatography, Thin Layer; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007532:Isoleucine / Q000378:metabolism / Q000494:pharmacology*; D007651:Keto Acids / Q000378:metabolism / Q000494:pharmacology*; D007739:L Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007930:Leucine / Q000494:pharmacology*; D008375:Maple Syrup Urine Disease / Q000097:blood*; D051379:Mice; D008854:Microscopy, Electron; D013997:Time Factors; D014316:Tritium; D014631:Valerates / Q000378:metabolism / Q000494:pharmacology*
D002210:Caprylates; D002250:Carbon Radioisotopes; D007651:Keto Acids; D014631:Valerates; D007532:Isoleucine; D014316:Tritium; D007930:Leucine